Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Geddes
Rob Butler

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
The Lancet. Psychiatry|September 14, 2015
Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trialDaniel Freeman, Felicity Waite, Helen Startup, et al.
Bjpsych Bulletin|February 1, 2024
Co-design of 'Ways of Being', a web-based experience to optimise online arts and culture for mental health in young peopleRebecca J Syed Sheriff, Eloise Sinclair, Jen Young, et al.
Journal of Medical Internet Research|January 16, 2020
The True Colours Remote Symptom Monitoring System: A Decade of EvolutionSarah M Goodday, Lauren Atkinson, Guy Goodwin, et al.
Journal of Affective Disorders|July 19, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trialMichael Berger, Timea Helter, Lumbini Azim, et al.
Journal of Crohn'S & Colitis|July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current CareDarren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Health Technology Assessment (Winchester, England)|May 12, 2025
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trialJess Kerr-Gaffney, Zohra Zenasni, Kimberley Goldsmith, et al.
Journal of Global Health|December 6, 2022
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026Natalya Chapman, Michael Browning, David Baghurst, et al.
Evidence-Based Mental Health|September 29, 2021
Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health TrustsJames Sw Hong, Rebecca Sheriff, Katharine Smith, et al.
Health Technology Assessment (Winchester, England)|April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trialThomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Circulation|March 27, 2014
Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experiencePatrick A Calvert, James Cockburn, Dylan Wynne, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
The Lancet. Psychiatry|September 14, 2015
Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trialDaniel Freeman, Felicity Waite, Helen Startup, et al.
Bjpsych Bulletin|February 1, 2024
Co-design of 'Ways of Being', a web-based experience to optimise online arts and culture for mental health in young peopleRebecca J Syed Sheriff, Eloise Sinclair, Jen Young, et al.
Journal of Medical Internet Research|January 16, 2020
The True Colours Remote Symptom Monitoring System: A Decade of EvolutionSarah M Goodday, Lauren Atkinson, Guy Goodwin, et al.
Journal of Affective Disorders|July 19, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trialMichael Berger, Timea Helter, Lumbini Azim, et al.
Journal of Crohn'S & Colitis|July 22, 2022
Patient-reported Outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in Real-life Practice Helps Quantify Deficits in Current CareDarren Wong, Lawrence Matini, Andrey Kormilitzin, et al.
Health Technology Assessment (Winchester, England)|May 12, 2025
Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trialJess Kerr-Gaffney, Zohra Zenasni, Kimberley Goldsmith, et al.
Journal of Global Health|December 6, 2022
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026Natalya Chapman, Michael Browning, David Baghurst, et al.
Evidence-Based Mental Health|September 29, 2021
Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health TrustsJames Sw Hong, Rebecca Sheriff, Katharine Smith, et al.
Health Technology Assessment (Winchester, England)|April 21, 2016
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trialThomas R E Barnes, Verity C Leeson, Carol Paton, et al.
Circulation|March 27, 2014
Percutaneous closure of postinfarction ventricular septal defect: in-hospital outcomes and long-term follow-up of UK experiencePatrick A Calvert, James Cockburn, Dylan Wynne, et al.
Pageof 15